Dipna Pharmachem Past Earnings Performance
Past criteria checks 2/6
Dipna Pharmachem has been growing earnings at an average annual rate of 32.4%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 31.4% per year. Dipna Pharmachem's return on equity is 2.9%, and it has net margins of 0.7%.
Key information
32.4%
Earnings growth rate
-14.0%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 31.4% |
| Return on equity | 2.9% |
| Net Margin | 0.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dipna Pharmachem makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,643 | 11 | 1 | 0 |
| 31 Dec 23 | 1,448 | 11 | 1 | 0 |
| 30 Sep 23 | 1,254 | 12 | 1 | 0 |
| 30 Jun 23 | 1,126 | 10 | 1 | 0 |
| 31 Mar 23 | 999 | 9 | 1 | 0 |
| 31 Dec 22 | 960 | 10 | 0 | 0 |
| 30 Sep 22 | 921 | 12 | 6 | 0 |
| 30 Jun 22 | 824 | 12 | 6 | 0 |
| 31 Mar 22 | 728 | 12 | 1 | 0 |
| 31 Mar 21 | 310 | 0 | 4 | 0 |
| 31 Mar 20 | 305 | 1 | 4 | 0 |
| 31 Mar 19 | 202 | 0 | 0 | 0 |
| 31 Mar 18 | 166 | 1 | 0 | 0 |
| 31 Mar 16 | 98 | 0 | 0 | 0 |
| 31 Mar 15 | 79 | 0 | 0 | 0 |
Quality Earnings: 543594 has high quality earnings.
Growing Profit Margin: 543594's current net profit margins (0.7%) are lower than last year (0.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543594's earnings have grown significantly by 32.4% per year over the past 5 years.
Accelerating Growth: 543594's earnings growth over the past year (19%) is below its 5-year average (32.4% per year).
Earnings vs Industry: 543594 earnings growth over the past year (19%) did not outperform the Healthcare industry 33.2%.
Return on Equity
High ROE: 543594's Return on Equity (2.9%) is considered low.